Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003401
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Active Not RecruitingNCT03606577
What this trial is testing

An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Nantes University Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT00818649
What this trial is testing

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 16
Early research (Phase 1)Looking for participantsNCT05544019
What this trial is testing

Study of SGR-1505 in Mature B-Cell Neoplasms

Who this might be right for
Mature B-Cell NeoplasmNon Hodgkin LymphomaDLBCL+23 more
Schrödinger, Inc. 98
Not applicableStudy completedNCT00660400
What this trial is testing

Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Leukemia
H. Lee Moffitt Cancer Center and Research Institute 25
Testing effectiveness (Phase 2)Study completedNCT00002598
What this trial is testing

Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 30
Not applicableWithdrawnNCT03141398
What this trial is testing

Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group

Who this might be right for
Iron OverloadHemoglobinopathiesLymphoma+1 more
Hamad Medical Corporation
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT03952832
What this trial is testing

Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00007852
What this trial is testing

Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska 44
Early research (Phase 1)Study completedNCT01163357
What this trial is testing

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Ended earlyNCT03067571
What this trial is testing

Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
High Risk Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 7
Not applicableNot Yet RecruitingNCT07806084
What this trial is testing

Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSF

Who this might be right for
Breast CancerChemotherapy-Induced NeutropeniaFebrile Neutropenia+1 more
The First Affiliated Hospital with Nanjing Medical University 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07575412
What this trial is testing

SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more
The First Affiliated Hospital of Soochow University 180
Testing effectiveness (Phase 2)Ended earlyNCT02128230
What this trial is testing

UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Who this might be right for
Multiple Myeloma
University of Arkansas 20
Testing effectiveness (Phase 2)Study completedNCT00303667
What this trial is testing

Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT01686334
What this trial is testing

Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia
Zwi Berneman 130
Large-scale testing (Phase 3)Looking for participantsNCT07413809
What this trial is testing

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Who this might be right for
Multiple Myeloma
The Affiliated People's Hospital of Ningbo University 92
Early research (Phase 1)Active Not RecruitingNCT02935257
What this trial is testing

Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19

Who this might be right for
Leukemia, Lymphoblastic, Acute, Lymphoma
University College, London 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07643636
What this trial is testing

Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML

Who this might be right for
AML (Acute Myeloid Leukemia)
Dongguan People's Hospital 46
Next Page